Spermosens Feed

	Est. tid*
2025-11-12	08:00	Kvartalsrapport 2025-Q3
2025-08-20	08:00	Kvartalsrapport 2025-Q2
2025-06-16	-	Årsstämma
2025-05-09	-	X-dag ordinarie utdelning SPERM 0.00 SEK
2025-05-07	-	Kvartalsrapport 2025-Q1
2025-02-17	-	Extra Bolagsstämma 2025
2025-02-12	-	Bokslutskommuniké 2024
2024-11-28	-	Kvartalsrapport 2024-Q3
2024-08-20	-	Kvartalsrapport 2024-Q2
2024-05-30	-	Kvartalsrapport 2024-Q1
2024-05-13	-	X-dag ordinarie utdelning SPERM 0.00 SEK
2024-05-10	-	Årsstämma
2024-03-25	-	Extra Bolagsstämma 2024
2024-02-09	-	Bokslutskommuniké 2023
2023-10-13	-	Kvartalsrapport 2023-Q3
2023-07-14	-	Kvartalsrapport 2023-Q2
2023-05-15	-	X-dag ordinarie utdelning SPERM 0.00 SEK
2023-05-12	-	Årsstämma
2023-04-19	-	Kvartalsrapport 2023-Q1
2023-02-24	-	Bokslutskommuniké 2022
2022-12-19	-	Extra Bolagsstämma 2022
2022-10-14	-	Kvartalsrapport 2022-Q3
2022-07-14	-	Kvartalsrapport 2022-Q2
2022-05-13	-	X-dag ordinarie utdelning SPERM 0.00 SEK
2022-05-12	-	Årsstämma
2022-04-12	-	Kvartalsrapport 2022-Q1
2022-02-10	-	Bokslutskommuniké 2021
2021-11-11	-	Kvartalsrapport 2021-Q3
2021-08-19	-	Kvartalsrapport 2021-Q2
2021-05-14	-	X-dag ordinarie utdelning SPERM 0.00 SEK
2021-05-12	-	Årsstämma
2021-05-04	-	Kvartalsrapport 2021-Q1
2021-02-12	-	Bokslutskommuniké 2020

Land	Sverige
Lista	Spotlight
Sektor	Hälsovård
Industri	Medicinteknik

2025-06-17 14:16:07 Spermosens announces outcome of exercise of warrants series TO 5 0,01 SEK | +7,69% | 0,06 MSEK

2025-06-16 11:15:42 Spermosens AB Announces Results from Annual General Meeting on 16 June 2025 0,01 SEK | 0,00% | 0,05 MSEK

2025-06-13 13:04:02 Chairman and CEO of Spermosens exercise TO5 warrants 0,01 SEK | -9,30% | 0,16 MSEK

2025-06-11 12:48:55 Spermosens concludes clinical study with statistically significant results supporting the diagnostic value of JUNO-Checked 0,01 SEK | +28,57% | 1,70 MSEK

2025-06-05 21:09:15 Spermosens: The capital raise and issue announced in March 2025 is approved by Inspectorate of Strategic Products

2025-06-05 12:27:34 Last day of trading in warrants series TO 5 in Spermosens is 12 June 2025 0,01 SEK | 0,00% | 0,04 MSEK

2025-06-02 08:45:00 Spermosens: The subscription price for warrants of series TO 5 has been determined - the exercise period begins today 0,01 SEK | -15,38% | 0,14 MSEK

2025-05-26 12:06:17 Spermosens publishes annual report for the financial year 2024 0,01 SEK | 0,00% | 0,02 MSEK

2025-05-26 12:04:18 Spermosens publicerar årsredovisning för räkenskapsåret 2024 0,01 SEK | 0,00% | 0,02 MSEK

2025-05-15 08:51:00 Spermosens: NOTICE OF ANNUAL GENERAL MEETING 2025 IN SPERMOSENS AB (publ) 0,01 SEK | -2,50% | 0,01 MSEK

2025-05-15 08:50:00 Spermosens: KALLELSE TILL ÅRSSTÄMMA 2025 I SPERMOSENS AB (publ) 0,01 SEK | -2,50% | 0,01 MSEK

2025-05-07 09:10:43 Spermosens AB (publ)INTERIM REPORT JANUARY - MARCH 2025 0,01 SEK | 0,00% | 0,04 MSEK

2025-04-30 12:48:53 Spermosens provides update on clinical progress, partner discussions and financing 0,01 SEK | +10,81% | 0,03 MSEK

2025-04-02 09:56:37 Spermosens reports positive second interim results from clinical study 0,01 SEK | -6,12% | 0,75 MSEK

2025-03-31 08:45:00 Spermosens appoints Dr. Jaime Castillo-León as chief technology officer to drive innovation and technology development 0,01 SEK | +2,17% | 0,06 MSEK

2025-03-27 09:56:40 Spermosens AB announces strategic collaboration with Scalania AG to accelerate development and market readiness 0,01 SEK | 0,00% | 0,20 MSEK

2025-03-21 12:28:19 Spermosens publishes peer-reviewed article on JUNO-Checked technology 0,01 SEK | +6,98% | 0,04 MSEK

2025-03-14 12:44:05 Spermosens presents plan to achieve positive cash flow following recent strategic investment 0,01 SEK | +17,07% | 0,48 MSEK

2025-03-05 14:30:32 Spermosens announces outcome of TO3 warrants 0,01 SEK | 0,00% | 0,32 MSEK

2025-03-04 13:33:03 Spermosens secures SEK 10.8 million strategic investment through directed issue, fulfilling capital need until cash positive 0,01 SEK | +14,29% | 2,34 MSEK

2025-02-24 15:49:24 Spermosens announces last day of trading for warrants of series TO3 0,01 SEK | -2,50% | 0,01 MSEK

2025-02-19 15:54:38 Spermosens AB announces shareholding changes following latest directed issue 0,01 SEK | +2,50% | 0,01 MSEK

2025-02-17 16:00:00 Announcement from the Extraordinary General Meeting of Spermosens AB (publ) on 17 February 2025 0,01 SEK | 0,00% | 0,06 MSEK

2025-02-17 16:00:00 Kommuniké från extra bolagsstämma i Spermosens AB (publ) den 17 februari 2025 0,01 SEK | 0,00% | 0,06 MSEK

2025-02-13 20:54:06 Spermosens AB (publ) YEAR-END REPORT JANUARY - DECEMBER 2024 0,01 SEK | -2,44% | 0,01 MSEK

2025-02-13 13:26:49 Spermosens adjusts publication date for Year-end report 2024 0,01 SEK | +2,50% | 0,01 MSEK

2025-01-15 14:45:00 Kallelse till extra bolagsstämma i Spermosens AB 0,01 SEK | -2,50% | 0,10 MSEK

2025-01-14 12:09:27 Spermosens announces relocation to a smaller office at Medicon Village 0,01 SEK | -9,09% | 0,19 MSEK

2024-12-30 11:54:43 Spermosens year-end status update: Strong progress and promising outlook for 2025 0,01 SEK | +21,82% | 0,08 MSEK

2024-12-23 15:00:00 Spermosens announces the last day of trading in BTU and the first day of trading in warrants series TO 5 and TO 6 0,01 SEK | -14,29% | 0,09 MSEK

2024-12-23 08:53:27 Spermosens carries out directed issues of approx. MSEK 5.59, takes up credit facility of MSEK 1.00, and receives proposal of directed issues of approx. MSEK 0.39 0,01 SEK | -14,29% | 0,09 MSEK

2024-12-19 12:21:43 Spermosens announces positive results from ongoing clinical study 0,02 SEK | +51,67% | 0,85 MSEK

2024-11-27 21:00:00 Spermosens publishes outcome in rights issue 0,02 SEK | +4,00% | 0,06 MSEK

2024-11-22 08:00:00 The subscription period in Spermosens' rights issue of units ends on Monday, 25 November 2024 0,01 SEK | -18,75% | 0,10 MSEK

2024-11-20 10:39:48 Spermosens' commercial strategy targets billion-dollar sperm bank market through global partnerships 0,02 SEK | +37,93% | 0,71 MSEK

2024-11-18 14:26:43 Spermosens provides update on clinical study progress 0,01 SEK | -17,33% | 0,05 MSEK

2024-11-11 08:00:00 The subscription period in Spermosens' rights issue of units begins today 0,01 SEK | -23,26% | 0,04 MSEK

2024-11-06 20:00:00 Spermosens publishes information memorandum due to upcoming rights issue of units 0,02 SEK | -3,03% | 0,10 MSEK

2024-11-05 12:17:54 Spermosens announces advancements in second-generation JUNO-Checked system 0,01 SEK | -0,69% | 0,16 MSEK

2024-11-04 20:00:00 Announcement from the Extraordinary General Meeting of Spermosens AB (publ) 0,01 SEK | -0,69% | 0,16 MSEK

2024-11-04 20:00:00 Kommuniké från extra bolagsstämma i Spermosens AB (publ) 0,01 SEK | -0,69% | 0,16 MSEK

2024-10-30 13:20:18 Spermosens reduces spending by focusing on clinical study and business development 0,01 SEK | +5,11% | 0,02 MSEK

2024-10-24 20:00:00 Spermosens AB (publ)INTERIM REPORT JANUARY - SEPTEMBER 2024 0,01 SEK | +13,28% | 0,03 MSEK

2024-10-23 13:25:38 Spermosens reports strong progress in clinical study 0,01 SEK | +22,02% | 0,26 MSEK

2024-10-16 14:30:00 Spermosens signs memorandum of understanding for commercial partnership in Japan 0,01 SEK | +36,36% | 0,49 MSEK

2024-10-15 14:10:47 Spermosens receives notice of allowance for broad US patent covering JUNO-Checked technology 0,01 SEK | +17,86% | 0,41 MSEK

2024-10-04 14:00:00 Spermosens recruits first couple for clinical study on next-generation male fertility diagnostic product 0,01 SEK | -31,13% | 0,27 MSEK

2024-10-03 21:13:25 Kallelse till extra bolagsstämma i Spermosens AB (publ) för beslut om emission 0,01 SEK | -31,13% | 0,27 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Spermosens

Kalender

Beskrivning

Spermosens

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden